HomeInsightsDividend

Bliss GVS Pharma Ltd dividend

Bliss GVS Pharma Ltd dividend

download
stocks purchased

₹ 0.5 Cr

Volume transacted

stocks purchased

40.7 K

stocks traded

Last Updated time: 23 Jul 9.00 AM

Image

Bliss GVS Pharma Ltd

NSE: BLISSGVS

DPS

0.5

Last updated : FY 2024

Key Highlights

    The Dividend per Share of Bliss GVS Pharma Ltd is ₹ 0.5 as of 2024 .a1#The Dividend Payout of Bliss GVS Pharma Ltd changed from 13.85 % on March 2019 to 10.34 % on March 2024 . This represents a CAGR of -4.75% over 6 years. a1#The Latest Trading Price of Bliss GVS Pharma Ltd is ₹ 112.15 as of 23 Jul 15:30 .a1#The Market Cap of Bliss GVS Pharma Ltd changed from ₹ 1856 crore on March 2019 to ₹ 1179 crore on March 2024 . This represents a CAGR of -7.28% over 6 years. a1#The Revenue of Bliss GVS Pharma Ltd changed from ₹ 195.67 crore to ₹ 203.73 crore over 8 quarters. This represents a CAGR of 2.04% a1#The EBITDA of Bliss GVS Pharma Ltd changed from ₹ 45.86 crore to ₹ 4.75 crore over 8 quarters. This represents a CAGR of -67.82% a1#The Net Pr of Bliss GVS Pharma Ltd changed from ₹ 27.48 crore to ₹ -4.91 crore over 8 quarters. This represents a CAGR of NaN% a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Share Price Vs Dividend Yield

swot
swot

Company Fundamentals For Bliss GVS Pharma Ltd

Market Cap

1,142 Cr

EPS

9.1

P/E Ratio (TTM) *

11.9

P/B Ratio (TTM) *

1.2

DTE *

0.1

ROE *

9.9

ROCE *

14.3

Dividend Yield *

0.44

DPS *

0.5

Dividend Payout *

10.34

Ann.Dividend % *

50

* All values are consolidated

Last Updated time: 23 Jul 9.00 AM

* All values are consolidated

Last Updated time: 23 Jul 9.00 AM

×

Historical Dividend Payout of Bliss GVS Pharma Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Bliss GVS Pharma Ltd

Period
Mar '1914
Mar '206
Mar '218
Mar '226
Mar '236
Mar '2410

* All values are a in %

Dividend per Share (DPS) Over Time

×

DIVIDENDYIELD

Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.

Dividend Yield Comparison With Top Peers

1M

1Y

3Y

5Y

* All values are in %

Net Profit Vs Dividend Per Share

Image

Bliss GVS Pharma Ltd

NSE: BLISSGVS

PRICE

112.15

3.25 (2.98%)

stock direction

Last updated : 23 Jul 15:30

SWOT Analysis Of Bliss GVS Pharma Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

Overview of Dividend

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


×

Historical Market Cap of Bliss GVS Pharma Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Bliss GVS Pharma Ltd

Period
Mar '191856
Mar '201040
Mar '211018
Mar '22798
Mar '23742
Mar '241179

* All values are a in crore

×

Historical Revenue of Bliss GVS Pharma Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Bliss GVS Pharma Ltd

Period
Jun '22196
Sep '22175
Dec '22211
Mar '23188
Jun '23165
Sep '23224
Dec '23206
Mar '24204

* All values are a in crore

×

Historical EBITDA of Bliss GVS Pharma Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Bliss GVS Pharma Ltd

Period
Jun '2246
Sep '2227
Dec '2253
Mar '239
Jun '2329
Sep '2367
Dec '2349
Mar '245

* All values are a in crore

×

Historical Net Profit of Bliss GVS Pharma Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Bliss GVS Pharma Ltd

Period
Jun '2227
Sep '2216
Dec '2230
Mar '233
Jun '2314
Sep '2343
Dec '2329
Mar '24-5

* All values are a in crore

About Bliss GVS Pharma Ltd

About Bliss GVS Pharma Ltd

    Bliss GVS Pharma Ltd is an export-oriented pharmaceutical company. It is among the world leaders in Suppositories and Pessaries dosage forms with one of the largest portfolios in this segment. Bliss GVS Pharma has presence in antimalarial, antifungal, antibacterial, anti-inflammatory and antibiotic therapeutic segments. It is a leading player in the antimalarial branded formulations segment. Bliss GVS Pharma is the only EU-GMP certified suppositories manufacturer in India. The company has a dedicated the R&D Centre for development of Suppositories, Semi Solids and Oral Solids with an experienced Team of over 50 Scientists for formulation development and analytical method development and certified by the Department of Scientific & Industrial Research (DSIR), Government of India. Incorporated in 1984 as a private limited company under the name Bliss Chemicals & Pharmaceuticals India Ltd, the company commenced its business in 1985. In 1994 the company introduced a new pharmaceutical product VAGID.During the financial year ended 31 March 2014, Bliss GVS Pharma's R&D center, received approval from Government of India's Department for Scientific & Industrial Research (DSIR). During the year under review, the company invested in 51% share capital of Lifeon Labs Pvt Ltd. During the year under review, Bliss GVS Pharma faced challenges in Ghana, where delays in registration resulted in adverse regulatory action. However, the company took quick, corrective measures to resolve these issues. The business is now backing on track in Ghana. During the year ended 31 March 2015, Bliss GVS Pharma formed a new company Asterisk Lifesciences Limited as a wholly owned foreign subsidiary in United Kingdom for the purpose of facilitating registrations and marketing of pharmaceutical formulations in the European continent. During the financial year ended 31 March 2016, Bliss GVS Pharma continued to grow in various geographies in Kenya, Nigeria and France. Such growth was mainly achieved due to contract manufacturing and consistent focus on new product launch in Kenya and Nigeria. Bliss GVS Pharma continued to strengthen its operations and creation of robust Quality Manufacturing operations during the year ended 31 March 2017, The company's investment in managed healthcare services delivered encouraging results with the company procuring USD 111.40 mMillion contract from Aon. This presents a great platform for the unit to build on its recent success to successfully bid for other such contracts. During the year ended 31 March 2018, Bliss GVS Pharma divested three subsidiaries viz. Lifeon Labs Private Limited, Bliss Indasi Lifescience Private Limited and Shree Salespack Private Limited and one materially significant step down subsidiary Bliss GVS Healthcare Limited, Nairobi to focus on its core pharmaceutical operations, which have been a steady source of growth. As on 31 March 2019,the company has one domestic and 3 overseas subsidiaries. During the FY2020,the Company has completed the commissioning & qualification of Phase-I for its new state of the art multi-product facility situated at Palghar East in Maharashtra. This is the largest manufacturing unit of the Company in terms of planned production capacity when completed. It is equipped with state-of-the-art process equipment & utilities with a large part of the manufacturing process automated for enhanced levels of productivity, efficiency & compliance while reducing manual intervention. The unit is spread on an overall area of about 200,000 sq. ft. and is intended to further augment the production capacities for the Company. The Company has 4 wholly owned subsidiaries and 3 step-down subsidiaries as on 31 March 2020. During the year, ECO Rich Cosmetics India Private Limited discontinued or ceased to be a step-down subsidiary of the Company consequent to loss of control. The Company's wholly owned subsidiary Bliss GVS Clinic HealthCare Pte. Ltd. situated at Singapore became a material subsidiary for the Company during the financial year 2019-2020.

Bliss GVS Pharma Ltd News Hub

News

Bliss GVS Pharma to convene board meeting

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 July 2...

Read more

18 Jul 202411:35

News

Bliss GVS Pharma to convene AGM

Bliss GVS Pharma announced that the 39th Annual General Meeting(AGM) of the company will b...

Read more

04 May 202416:04

News

Board of Bliss GVS Pharma recommends final dividend

Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held ...

Read more

03 May 202410:36

News

Bliss GVS Pharma announces board meeting date

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 2 May 202...

Read more

26 Apr 202411:02

News

Bliss GVS Pharma to discuss results

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 23 Januar...

Read more

17 Jan 202411:25

News

Bliss GVS Pharma to discuss results

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 1 Novembe...

Read more

26 Oct 202315:28

FAQs for dividends of Bliss GVS Pharma Ltd

What is the current market price of Bliss GVS Pharma Ltd Ltd as of July 23, 2024?

The current market price of Bliss GVS Pharma Ltd Ltd stands at 112.2 per share.

What dividend did Bliss GVS Pharma Ltd declare in the last fiscal year?

In the last fiscal year, Bliss GVS Pharma Ltd declared a dividend totaling ₹0.5.

What is the most recent dividend declared by Bliss GVS Pharma Ltd?

Bliss GVS Pharma Ltd recently declared a dividend of 0.0 in the latest quarter

How many times has Bliss GVS Pharma Ltd declared dividends in the current fiscal year

Bliss GVS Pharma Ltd has declared dividends 4 times totaling ₹0 in the current fiscal year (FY2023-2024).

How many times did Bliss GVS Pharma Ltd declare dividends in the previous fiscal year?

In the previous fiscal year (FY2022-2023), Bliss GVS Pharma Ltd declared dividends 4 times totaling ₹0.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199